Thomas Reiser/LinkedIn
Nov 20, 2025, 13:42
Rebalancing Therapies Poised to Transform Hemophilia Care․ Explore the New ISTH CME
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared on X:
” New ISTH CME activity available:
Rebalancing Therapies for Hemophilia Are You Ready?
Gain the latest insights on emerg. rebalancing treatments, compare evolving clin. profiles & learn how to prepare your team for what’s next in hemophilia care.”
Read more here.
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:23Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants